Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-10-31

Study Completion Date

2006-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

serum levels Ca, P, PTH and vitamin D metabolites before and after treatment with isotretinoin for sever acne

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Relationship Between Serum Vitamin D Levels and Musculoskeletal Adverse Effects in Patients Using Isotretinoin

NCT04204304

Musculoskeletal Disease Other Isotretinoin Adverse Reaction Vitamin D Deficiency

COMPLETED NA

The Effect of Vitamin A on Atherosclerosis

NCT01414972

Atherosclerosis

UNKNOWN PHASE4

The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3

NCT01633658

Vitamin D Deficiency

WITHDRAWN NA

Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol

NCT05104970

Vitamin D Deficiency

UNKNOWN PHASE2

Vitamin D and Genetics in Nutritional Rickets

NCT00949832

Nutritional Rickets

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

few studies has been done of serum levels Ca, P, PTH and vitamin D metabolites in patients receiving isotretinoin .In this study we measured serum levels Ca, P, PTH and vitamin D metabolites before and after treatment with isotretinoin for sever acne in 30 patients . the patients had no kown skeletal, endocrine ,renal and gastrointestinal disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acne

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

isotretinoin (Roaccutane)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* sever acne

Exclusion Criteria

* renal disorders
* gastrointestinal disorders
* skeletal disorders
* endocrine disorders
* drugs such as glucocorticoids , thiazide diuretics, mineral multivitamins, anti acids, tetracyclines

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes